[Association between weight control and recurrence of atrial fibrillation after catheter ablation in overweight and obese patients]
- PMID: 31434429
- DOI: 10.3760/cma.j.issn.0253-3758.2019.08.002
[Association between weight control and recurrence of atrial fibrillation after catheter ablation in overweight and obese patients]
Abstract
Objectives: This study explored the relationship between weight control and atrial fibrillation (AF) recurrence after catheter ablation in overweight and obese patients. Methods: We prospectively enrolled consecutive 333 overweight and obese patients aged 28 to 87 years old, who underwent catheter ablation for AF in Beijing Anzhen Hospital between October 2015 and February 2016. Data of patients' characteristics, laboratory examination and treatment were collected at baseline. Each patient was followed up at 3, 6 and 12 months after ablation to collect information on weight, AF recurrence, stroke, major bleeding, hospitalization for cardiovascular reasons and death, etc. Patients were divided into weight controlled group (ΔBMI<-1 kg/m(2)) and weight uncontrolled group (ΔBMI≥-1 kg/m(2)), according to the changes in the most recent exposure BMI before AF recurrence in patients with recurrence or the BMI at 12 months' follow-up in patients without recurrence and the BMI at baseline. Multivariate logistic regression was performed to adjust other known risk factors of AF recurrence and to explore the association between weight control and AF recurrence after catheter ablation. Results: There were 54 patients in weight controlled group and 279 patients in weight uncontrolled group. There were no significant differences in age, gender, education level, left atrial size and history of hypertension between the two groups (all P>0.05). The proportion of patients using angiotensin-converting enzyme inhibitors/angiotensin receptor blockers was higher in the weight controlled group (50.0%(27/54) vs. 34.8%(97/279), P=0.034). However, there was no significant difference in the proportion of patients with obesity (33.3% (18/54) vs. 29.7% (83/279)), paroxysmal AF (59.3% (32/54) vs. 56.6% (158/279)) and AF duration less than 5 years (76.9% (40/52) vs. 65.4% (178/272)) between the weight controlled group and the uncontrolled group. During 1-year follow-up after ablation, the recurrence rate of AF was significantly lower in the weight controlled group than that in the weight uncontrolled group (14.8% (8/54) vs. 32.6%(91/279), P=0.009). Multivariable logistic regression analysis shows that weight control is independently associated with a lower postoperative AF recurrence rate (OR=0.40, 95%CI 0.18-0.90, P=0.026). Conclusion: Weight control is strongly associated with a lower AF recurrence rate after catheter ablation in overweight and obese patients.
目的: 探讨体重控制与超重及肥胖患者心房颤动(房颤)射频消融术后复发的关系。 方法: 前瞻性连续入选2015年10月至2016年2月于首都医科大学附属北京安贞医院接受房颤射频消融治疗的超重及肥胖患者333例,年龄28~87岁,收集患者基线时的临床特征、实验室检查及治疗等信息,并分别在术后的第3、6和12个月进行随访,收集体重、房颤复发、卒中、大出血、心血管原因住院、死亡等信息。根据随访的BMI较基线的变化情况,将研究人群分为体重控制组(ΔBMI<-1 kg/m(2))及体重未控制组(ΔBMI≥-1 kg/m(2)),出现房颤复发者采用复发前最后一次的BMI结果,无房颤复发者采用术后第12个月随访时的BMI结果。用logistic多因素回归分析校正其他已知的影响房颤复发的因素,探讨体重控制与房颤射频消融术后房颤复发之间的关系。 结果: 体重控制组54例,体重未控制组279例。两组患者的年龄、性别、教育程度、左心房大小、合并高血压等的比例差异无统计学意义(P>0.05)。与体重未控制组比较,体重控制组中使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂的患者比例较高[50.0%(27/54)比34.8%(97/279),P=0.034],但体重控制组中肥胖[33.3%(18/54)比29.7%(83/279)]、阵发性房颤[59.3%(32/54)比56.6%(158/279)]和房颤病程<5年[76.9%(40/52)比65.4%(178/272)]的患者比例与体重未控制组比较,差异均无统计学意义(P均>0.05)。此外,在房颤消融术后随访1年中,体重控制组房颤复发率明显低于体重未控制组[14.8%(8/54)比32.6%(91/279),P=0.009]。多因素logistic回归分析显示体重控制与房颤消融术后复发率低显著相关(OR=0.40,95%CI 0.18~0.90,P=0.026)。 结论: 在超重及肥胖患者中,体重控制与房颤射频消融术后房颤复发率低具有相关性。.
Keywords: Atrial fibrillation; Body weight; Catheter ablation; Recurrence.
Similar articles
-
[Left atrial appendage volume is a valuable predictor of atrial fibrillation recurrence after radiofrequency catheter ablation].Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Nov 24;45(11):924-929. doi: 10.3760/cma.j.issn.0253-3758.2017.11.006. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29166717 Chinese.
-
Low left atrial appendage flow velocity predicts recurrence of atrial fibrillation after catheter ablation of persistent atrial fibrillation.J Cardiol. 2015 Nov;66(5):377-81. doi: 10.1016/j.jjcc.2015.04.009. Epub 2015 May 14. J Cardiol. 2015. PMID: 25982670
-
Impact of body mass index on the outcome of catheter ablation of atrial fibrillation.Heart. 2019 Feb;105(3):244-250. doi: 10.1136/heartjnl-2018-313490. Epub 2018 Oct 2. Heart. 2019. PMID: 30279268
-
Impact of body mass index on atrial fibrillation recurrence: a meta-analysis of observational studies.Pacing Clin Electrophysiol. 2013 Jun;36(6):748-56. doi: 10.1111/pace.12106. Epub 2013 Feb 25. Pacing Clin Electrophysiol. 2013. PMID: 23437987
-
Benefit of left atrial appendage electrical isolation for persistent and long-standing persistent atrial fibrillation: a systematic review and meta-analysis.Europace. 2018 Aug 1;20(8):1268-1278. doi: 10.1093/europace/eux372. Europace. 2018. PMID: 29342299
Cited by
-
Feasibility of weight loss in obese atrial fibrillation patients attending a specialist arrhythmia clinic and its impact on ablation outcomes.J Arrhythm. 2020 Sep 13;36(6):984-990. doi: 10.1002/joa3.12432. eCollection 2020 Dec. J Arrhythm. 2020. PMID: 33335614 Free PMC article.
-
The Management of Obesity Before Catheter Ablation of AF: The Missing Piece?Arrhythm Electrophysiol Rev. 2025 May 19;14:e09. doi: 10.15420/aer.2024.45. eCollection 2025. Arrhythm Electrophysiol Rev. 2025. PMID: 40458371 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical